{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:39:09Z","timestamp":1792643949786,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-026-03260-9","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T02:49:09Z","timestamp":1785206949000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["lncRNA ZNF667-AS1 suppresses hepatitis B virus-related hepatocellular carcinoma by regulating miR-210-3p to upregulate CPEB2"],"prefix":"10.1186","volume":"23","author":[{"given":"Huimin","family":"Cong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guobing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzhou","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"issue":"1","key":"3260_CR1","doi-asserted-by":"publisher","first-page":"14505","DOI":"10.1038\/s41598-018-32798-0","volume":"8","author":"G Chen","year":"2018","unstructured":"Chen G, Zhang J, Sun J, Wei S, Chen J, Ren H, et al. Revisiting Partial Hepatectomy of Large Hepatocellular Carcinoma in Older Patients. Sci Rep. 2018;8(1):14505.","journal-title":"Sci Rep"},{"issue":"1","key":"3260_CR2","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12985-021-01668-z","volume":"18","author":"X Lv","year":"2021","unstructured":"Lv X, Xiang X, Wu Y, Liu Y, Xu R, Xiang Q, et al. GATA binding protein 4 promotes the expression and transcription of hepatitis B virus by facilitating hepatocyte nuclear factor 4 alpha in vitro. Virol J. 2021;18(1):196.","journal-title":"Virol J"},{"key":"3260_CR3","doi-asserted-by":"crossref","unstructured":"Kupke P, Brucker J, Wettengel JM, Protzer U, Wenzel JJ, Schlitt HJ et al. Cytokine Response of Natural Killer Cells to Hepatitis B Virus Infection Depends on Monocyte Co-Stimulation. Viruses. 2024;16(5).","DOI":"10.3390\/v16050741"},{"issue":"1","key":"3260_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12985-024-02291-4","volume":"21","author":"X Yao","year":"2024","unstructured":"Yao X, Xu K, Tao N, Cheng S, Chen H, Zhang D, et al. ZNF148 inhibits HBV replication by downregulating RXRalpha transcription. Virol J. 2024;21(1):35.","journal-title":"Virol J"},{"issue":"1","key":"3260_CR5","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41419-025-07605-0","volume":"16","author":"C Luo","year":"2025","unstructured":"Luo C, Ma C, Xu G, Lu C, Ma J, Huang Y, et al. Hepatitis B surface antigen hijacks TANK-binding kinase 1 to suppress type I interferon and induce early autophagy. Cell Death Dis. 2025;16(1):304.","journal-title":"Cell Death Dis"},{"issue":"6","key":"3260_CR6","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.32604\/or.2024.047524","volume":"32","author":"J Yi","year":"2024","unstructured":"Yi J, Li B, Yin X, Liu L, Song C, Zhao Y, et al. CircMYBL2 facilitates hepatocellular carcinoma progression by regulating E2F1 expression. Oncol Res. 2024;32(6):1129\u201339.","journal-title":"Oncol Res"},{"key":"3260_CR7","doi-asserted-by":"crossref","unstructured":"Yuan Z, Hu S, Zhu Q, Fang Y, Liu X, Li S et al. UBE2V1 Promotes Hepatocellular Carcinoma Progression by Forming a Positive Feedback Loop with HIF-1alpha. Research (Wash D C). 2025;8:1041.","DOI":"10.34133\/research.1041"},{"issue":"1","key":"3260_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12985-026-03083-8","volume":"23","author":"Y Jin","year":"2026","unstructured":"Jin Y, Wu D, Yang W, Weng M, Li Y, Wang X, et al. Correction: Hepatitis B virus x protein induces epithelial-mesenchymal transition of hepatocellular carcinoma cells by regulating long non-coding RNA. Virol J. 2026;23(1):36.","journal-title":"Virol J"},{"key":"3260_CR9","doi-asserted-by":"publisher","first-page":"8367454","DOI":"10.1155\/2020\/8367454","volume":"2020","author":"Q Xie","year":"2020","unstructured":"Xie Q, Ju T, Zhou C, Zhai L. LncRNA RNCR3 Promotes the Progression of HCC by Activating the Akt\/GSK3beta Signaling Pathway. Evid Based Complement Alternat Med. 2020;2020:8367454.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"3260_CR10","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1038\/s41467-025-57367-8","volume":"16","author":"Y Gao","year":"2025","unstructured":"Gao Y, Zhang Z, Huang X, You M, Du C, Li N, et al. HBV-associated hepatocellular carcinomas inhibit antitumor CD8(+) T cell via the long noncoding RNA HDAC2-AS2. Nat Commun. 2025;16(1):2055.","journal-title":"Nat Commun"},{"issue":"11","key":"3260_CR11","doi-asserted-by":"publisher","first-page":"4942","DOI":"10.7150\/ijbs.112133","volume":"21","author":"ZB Du","year":"2025","unstructured":"Du ZB, Wu XM, Han T, Cai YX, Qian B, Shen YS, et al. MALAT1 promotes malignancy of HBV-related hepatocellular carcinoma by regulating IGF2BP3-mediated nuclear-cytoplasmic shuttling. Int J Biol Sci. 2025;21(11):4942\u201360.","journal-title":"Int J Biol Sci"},{"issue":"6","key":"3260_CR12","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.21037\/tcr-2025-233","volume":"14","author":"Y Liu","year":"2025","unstructured":"Liu Y, Kong X, Yu X, Qiao J, Yang K, Li Z, et al. Hepatitis B virus core\/capsid protein induces hepatocellular carcinoma progression via long non-coding RNA KCNQ1OT1\/miR-335-5p\/CDC7 axis. Transl Cancer Res. 2025;14(6):3319\u201335.","journal-title":"Transl Cancer Res"},{"key":"3260_CR13","doi-asserted-by":"publisher","first-page":"111183","DOI":"10.1016\/j.cellsig.2024.111183","volume":"119","author":"F Shi","year":"2024","unstructured":"Shi F, Jiang J, Wang B, Hong L, Zhang Y, Meng Y, et al. Hepatitis B virus X protein promotes tumor glycolysis by downregulating lncRNA OIP5-AS1\/HKDC1 in HCC. Cell Signal. 2024;119:111183.","journal-title":"Cell Signal"},{"issue":"1","key":"3260_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1615\/CritRevEukaryotGeneExpr.2021039224","volume":"32","author":"W Wei","year":"2022","unstructured":"Wei W, Huang X, Shen X, Lian J, Chen Y, Wang W, et al. Overexpression of IncRNA TPT1-AS1 Suppresses Hepatocellular Carcinoma Cell Proliferation by Downregulating CDK2. Crit Rev Eukaryot Gene Expr. 2022;32(1):1\u20139.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"3260_CR15","doi-asserted-by":"publisher","first-page":"938102","DOI":"10.3389\/fendo.2023.938102","volume":"14","author":"Z Wang","year":"2023","unstructured":"Wang Z, Gao P, Sun W, Rehman AU, Jiang J, Xu S, et al. Long noncoding RNA MyD88 functions as a promising diagnostic biomarker in hepatocellular carcinoma. Front Endocrinol (Lausanne). 2023;14:938102.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"3260_CR16","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1007\/s12033-023-00772-5","volume":"66","author":"D Tong","year":"2024","unstructured":"Tong D, Fan L. LncRNA ZNF667-AS1 Targets miR-523-3p\/KIF5C Axis to Hinder Colon Cancer Progression. Mol Biotechnol. 2024;66(6):1464\u201376.","journal-title":"Mol Biotechnol"},{"key":"3260_CR17","doi-asserted-by":"publisher","first-page":"3579547","DOI":"10.1155\/2022\/3579547","volume":"2022","author":"C Yu","year":"2022","unstructured":"Yu C, Chen W, Cai Y, Du M, Zong D, Qian L, et al. The lncRNA ZNF667-AS1 Inhibits Propagation, Invasion, and Angiogenesis of Gastric Cancer by Silencing the Expression of N-Cadherin and VEGFA. J Oncol. 2022;2022:3579547.","journal-title":"J Oncol"},{"issue":"5","key":"3260_CR18","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3892\/etm.2025.12850","volume":"29","author":"F Wu","year":"2025","unstructured":"Wu F, Zhang T, Mei X, Gao T. lncRNA ZNF667\u2013AS1 inhibits ovarian cancer progression by interacting with the TNF signaling pathway. Exp Ther Med. 2025;29(5):100.","journal-title":"Exp Ther Med"},{"issue":"5","key":"3260_CR19","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3892\/ol.2023.13771","volume":"25","author":"J Xue","year":"2023","unstructured":"Xue J, Zhao H, Fu Y, Liu X, Wu X. Integrated analysis of multiple transcriptomic data identifies ST8SIA6\u2013AS1 and LINC01093 as potential biomarkers in HBV\u2013associated liver cancer. Oncol Lett. 2023;25(5):185.","journal-title":"Oncol Lett"},{"issue":"42","key":"3260_CR20","doi-asserted-by":"publisher","first-page":"9279","DOI":"10.3748\/wjg.v22.i42.9279","volume":"22","author":"WM Cong","year":"2016","unstructured":"Cong WM, Bu H, Chen J, Dong H, Zhu YY, Feng LH, et al. Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update. World J Gastroenterol. 2016;22(42):9279\u201387.","journal-title":"World J Gastroenterol"},{"issue":"39","key":"3260_CR21","doi-asserted-by":"publisher","first-page":"42118","DOI":"10.18632\/oncotarget.5967","volume":"6","author":"CH Wang","year":"2015","unstructured":"Wang CH, Li M, Liu LL, Zhou RY, Fu J, Zhang CZ, et al. LRG1 expression indicates unfavorable clinical outcome in hepatocellular carcinoma. Oncotarget. 2015;6(39):42118\u201329.","journal-title":"Oncotarget"},{"key":"3260_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/JHC.S152202","volume":"5","author":"B Liang","year":"2018","unstructured":"Liang B, Yao S, Zhou J, Li Z, Liu T. Liver resection versus radiofrequency ablation for hepatitis B virus-related small hepatocellular carcinoma. J Hepatocell Carcinoma. 2018;5:1\u20137.","journal-title":"J Hepatocell Carcinoma"},{"issue":"5","key":"3260_CR23","doi-asserted-by":"publisher","first-page":"887","DOI":"10.7150\/jca.17747","volume":"8","author":"S Shang","year":"2017","unstructured":"Shang S, Li W, Qin X, Zhang S, Liu Y. Aided Diagnosis of Hepatocellular Carcinoma Using Serum Fucosylated Haptoglobin Ratios. J Cancer. 2017;8(5):887\u201393.","journal-title":"J Cancer"},{"key":"3260_CR24","doi-asserted-by":"publisher","first-page":"9752534","DOI":"10.1155\/2021\/9752534","volume":"2021","author":"Y Pan","year":"2021","unstructured":"Pan Y, Han G. Analysis of Clinical Characteristics of Hepatitis B and Alcohol-Related Liver Cancer. Comput Math Methods Med. 2021;2021:9752534.","journal-title":"Comput Math Methods Med"},{"issue":"4","key":"3260_CR25","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.21037\/tcr-23-2145","volume":"13","author":"Y Teng","year":"2024","unstructured":"Teng Y, Liu R. E2F-mediated POLA2 upregulation is correlated with macrophage infiltration and poor prognosis in hepatocellular carcinoma. Transl Cancer Res. 2024;13(4):1848\u201360.","journal-title":"Transl Cancer Res"},{"issue":"6","key":"3260_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3349\/ymj.2020.61.6.471","volume":"61","author":"H Feng","year":"2020","unstructured":"Feng H, Liu X. Interaction between ACOT7 and LncRNA NMRAL2P via Methylation Regulates Gastric Cancer Progression. Yonsei Med J. 2020;61(6):471\u201381.","journal-title":"Yonsei Med J"},{"issue":"10","key":"3260_CR27","doi-asserted-by":"publisher","first-page":"787","DOI":"10.5152\/tjg.2024.24150","volume":"35","author":"Y Ji","year":"2024","unstructured":"Ji Y, Chen X, Liu X, Huang J, Liu P, lncRNA. POLR2J4 Plays a Biomarker Role in Hepatitis B Virus-Related Hepatocellular Carcinoma Through Regulating miR-214-3p. Turk J Gastroenterol. 2024;35(10):787\u201394.","journal-title":"Turk J Gastroenterol"},{"issue":"1","key":"3260_CR28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s10020-021-00278-3","volume":"27","author":"J Wang","year":"2021","unstructured":"Wang J, Yin G, Bian H, Yang J, Zhou P, Yan K, et al. LncRNA XIST upregulates TRIM25 via negatively regulating miR-192 in hepatitis B virus-related hepatocellular carcinoma. Mol Med. 2021;27(1):41.","journal-title":"Mol Med"},{"key":"3260_CR29","doi-asserted-by":"publisher","first-page":"198788","DOI":"10.1016\/j.virusres.2022.198788","volume":"315","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Wang F, Wang Y. LncRNA TSPEAR-AS1 predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma and promotes metastasis via miR-1915-5p. Virus Res. 2022;315:198788.","journal-title":"Virus Res"},{"key":"3260_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.clinbiochem.2022.06.006","volume":"108","author":"C Mo","year":"2022","unstructured":"Mo C, Wu J, Sui J, Deng Y, Li M, Cao Z, et al. Long non-coding RNA LINC01793 as a potential diagnostic biomarker of hepatitis B virus-related hepatocellular carcinoma. Clin Biochem. 2022;108:56\u201362.","journal-title":"Clin Biochem"},{"issue":"5","key":"3260_CR31","doi-asserted-by":"publisher","first-page":"391","DOI":"10.5152\/tjg.2024.23314","volume":"35","author":"Y Pan","year":"2024","unstructured":"Pan Y, Cai M, Zhang F, Liu X, Li M, Xie B, et al. Diagnostic Significance of Serum Long Noncoding HOX Antisense Intergenic Ribonucleic Acid in Patients with Hepatitis B Virus Related Hepatocellular Carcinoma. Turk J Gastroenterol. 2024;35(5):391\u20137.","journal-title":"Turk J Gastroenterol"},{"key":"3260_CR32","doi-asserted-by":"publisher","first-page":"218004","DOI":"10.1016\/j.canlet.2025.218004","volume":"633","author":"N Zhang","year":"2025","unstructured":"Zhang N, Zhang X, Yan T, Liu F, Tian X, Ma C, et al. Extrachromosomal DNA (ecDNA) drives hepatocellular carcinoma malignancy through high-copy amplification of chromosome 1q21-derived PIP5K1A oncogene. Cancer Lett. 2025;633:218004.","journal-title":"Cancer Lett"},{"key":"3260_CR33","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1186\/s12935-020-01530-2","volume":"20","author":"J Tian","year":"2020","unstructured":"Tian J, Cui P, Li Y, Yao X, Wu X, Wang Z, et al. LINC02418 promotes colon cancer progression by suppressing apoptosis via interaction with miR-34b-5p\/BCL2 axis. Cancer Cell Int. 2020;20:460.","journal-title":"Cancer Cell Int"},{"issue":"3","key":"3260_CR34","doi-asserted-by":"publisher","first-page":"G401","DOI":"10.1152\/ajpgi.00269.2019","volume":"318","author":"A Morishita","year":"2020","unstructured":"Morishita A, Fujita K, Iwama H, Chiyo T, Fujihara S, Oura K, et al. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma. Am J Physiol Gastrointest Liver Physiol. 2020;318(3):G401\u20139.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"14","key":"3260_CR35","doi-asserted-by":"publisher","first-page":"e34288","DOI":"10.1016\/j.heliyon.2024.e34288","volume":"10","author":"A Adugna","year":"2024","unstructured":"Adugna A, Muche Y, Melkamu A, Jemal M, Belew H, Amare GA. Current updates on the molecular and genetic signals as diagnostic and therapeutic targets for hepatitis B virus-associated hepatic malignancy. Heliyon. 2024;10(14):e34288.","journal-title":"Heliyon"},{"key":"3260_CR36","doi-asserted-by":"crossref","unstructured":"You R, Yang Y, Yin G, Jiang H, Lu Y, Gui L et al. CPEB2 Suppresses Hepatocellular Carcinoma Epithelial-Mesenchymal Transition and Metastasis through Regulating the HIF-1alpha\/miR-210-3p\/CPEB2 Axis. Pharmaceutics. 2023;15(7).","DOI":"10.3390\/pharmaceutics15071887"},{"issue":"1","key":"3260_CR37","doi-asserted-by":"publisher","first-page":"100146","DOI":"10.1016\/j.iliver.2025.100146","volume":"4","author":"LQ Yao","year":"2025","unstructured":"Yao LQ, Diao YK, Gong JB, Gu LH, Xu JH, Wang MD, et al. MAGI2-AS3\/miR-450b-5p\/COLEC10 interaction network: A potential therapeutic and prognostic marker in hepatocellular carcinoma. ILIVER. 2025;4(1):100146.","journal-title":"ILIVER"},{"issue":"4","key":"3260_CR38","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.ncrna.2023.09.005","volume":"8","author":"X Jiang","year":"2023","unstructured":"Jiang X, Lu Y, Xie S, Chen Y, Liu X, Li S, et al. miR-624 accelerates the growth of liver cancer cells by inhibiting EMC3. Noncoding RNA Res. 2023;8(4):641\u20134.","journal-title":"Noncoding RNA Res"},{"issue":"10","key":"3260_CR39","doi-asserted-by":"publisher","first-page":"105660","DOI":"10.1016\/j.psj.2025.105660","volume":"104","author":"J Xiang","year":"2025","unstructured":"Xiang J, Jia B, Luo Z, He H, Zhang Y, Cui C, et al. miR-363-5p regulates liver disease via the MAPK\/ERK signaling pathway by targeting CPEB2 in chicken. Poult Sci. 2025;104(10):105660.","journal-title":"Poult Sci"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-026-03260-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-026-03260-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-026-03260-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:14:03Z","timestamp":1792642443000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-026-03260-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3260"],"URL":"https:\/\/doi.org\/10.1186\/s12985-026-03260-9","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"27 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval was obtained from the ethics committee of Rudong People\u2019s Hospital (Approval No. 2020056). The procedures used in this study adhere to the tenets of the Declaration of Helsinki. Written informed consent was obtained from all individual participants included in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Consent for publication was obtained for every person\u2019s data included in the study.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"245"}}